Building Our Pipeline is Based on Collaboration

Clovis is focused on partnering with companies and taking responsibility for developing and commercializing innovative products that may ultimately provide significant benefit to cancer patients.

We are actively evaluating potential in-licensing opportunities for cancer therapeutics, where significant unmet medical need exists or in subset patient populations where the compound may have significant promise.

If you are interested in learning more about collaboration opportunities with Clovis Oncology, or to discuss a compound currently in clinical development, please contact our business development team via email at